Argentina and Mexico, partners in a coronavirus vaccine

Argentina and Mexico partnered with Anglo-Swedish laboratory AstraZeneca for production and distribution of an experimental vaccine against coronavirus. Argentina will manufacture vaccine, while Mexico will take care of packaging and "equitable" distribution throughout region, except Brazil, Argentine President Alberto Fernández anunced on Wednesday at a press conference.

goal is "to produce between 150 and 250 million vaccines for all of Latin America by first half of 2021," said Argentine president. vaccine in question is developed by University of Oxford and is one of nearly twenty initiatives that are in various sts of human trials around world.

In late July, AstraZeneca said it was willing to produce 2 billion doses of vaccine at a low price per dose. Manufacturing costs are expected to be offset through government and private funding. agreement with Mexico and Argentina will be financed by foundation of Mexican magnate Carlos Slim. Fernández estimated that vaccine will have a value of between three and four dollars, which "is very significant for Latin America because it allows all countries to access it."